Guanhao Biotech Co.,Ltd. (SHE:300238)
China flag China · Delayed Price · Currency is CNY
16.38
+0.07 (0.43%)
Jul 4, 2025, 2:45 PM CST

Guanhao Biotech Company Description

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products primarily in China.

It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses.

The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis.

In addition, it offers artificial lens and medical instruments; and cell technology services. Its products can be used in neurosurgery, thoracic surgery, ophthalmology, dermatology, orthopedics, cosmetology, and other areas.

The company was founded in 1999 and is headquartered in Guangzhou, China.

Guanhao Biotech Co.,Ltd.
Country China
Founded 1999
Industry Biotechnology
Sector Healthcare
Employees 530
CEO Feng Zhao

Contact Details

Address:
No. 12 Yuyan Road
Guangzhou, 510530
China
Phone 86 20 3205 2806
Website guanhaobio.com

Stock Details

Ticker Symbol 300238
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100001575
SIC Code 3842

Key Executives

Name Position
Feng Zhao General Manager
Xu Qingrong Deputy GM and Secretary
Junhui Zhao CPA Deputy General Manager
Zhen You Deputy General Manager
Huaixin Hou Deputy General Manager
Xianggui Lin Deputy General Manager
Ruofeng Yi Chief Financial Officer
Prof. Guofeng Xu Chief Technology Officer